Regulation 66A Application for renewal of a parallel import licenceF1
The licensing authority may renew a parallel import licence in response to an application made in accordance with this regulation.
The applicant must be established in the F2United Kingdom.
The application must be—
made in writing;
signed by or on behalf of the applicant; and
unless the licensing authority directs otherwise, accompanied by any fee payable in connection with the application.
An application is treated as signed for the purposes of paragraph (3)(b) if it is signed with an electronic signature.
The application must be made so that it is received by the licensing authority within three months of the end of a period expiring 5 years after the date of grant or (as the case may be) latest renewal of the licence.
Annotations
Textual amendments
- F1
Reg. 66A inserted (E.W.S.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.I. 2014/1878), regs. 1, 10 and reg. 66A inserted (N.I.) (1.10.2014) by The Human Medicines (Amendment) (No. 2) Regulations 2014 (S.R. 2014/324), regs. 1(1), 10
- F2
Words in reg. 66A(2) substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 75; 2020 c. 1, Sch. 5 para. 1(1)